Absorption, metabolism and excretion of [14C]-sotorasib in healthy male subjects: characterization of metabolites and a minor albumin-sotorasib conjugate-Reference-Cited by-同舟云学术

Absorption, metabolism and excretion of [14C]-sotorasib in healthy male subjects: characterization of metabolites and a minor albumin-sotorasib conjugate

Published:2022-09-05 Issue:4 Volume:90 Page:357-367
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Vuu Irene^ORCID,Dahal Upendra P.,Wang Zhe,Shen Xiaomeng,Rodgers John,Wahlstrom Jan,Houk Brett

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-022-04470-y.pdf

Reference20 articles.

1. Canon J, Rex K, Saiki AY, Mohr C, Cooke K, Bagal D, Gaida K, Holt T, Knutson CG, Koppada N, Lanman BA, Werner J, Rapaport AS, San Miguel T, Ortiz R, Osgood T, Sun JR, Zhu X, McCarter JD, Volak LP, Houk BE, Fakih MG, O’Neil BH, Price TJ, Falchook GS, Desai J, Kuo J, Govindan R, Hong DS, Ouyang W, Henary H, Arvedson T, Cee VJ, Lipford JR (2019) The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature 575(7781):217–223. https://doi.org/10.1038/s41586-019-1694-1 (Epub 2019 Oct 30 PMID: 31666701)

2. Lanman BA, Allen JR, Allen JG, Amegadzie AK, Ashton KS, Booker SK, Chen JJ, Chen N, Frohn MJ, Goodman G, Kopecky DJ, Liu L, Lopez P, Low JD, Ma V, Minatti AE, Nguyen TT, Nishimura N, Pickrell AJ, Reed AB, Shin Y, Siegmund AC, Tamayo NA, Tegley CM, Walton MC, Wang HL, Wurz RP, Xue M, Yang KC, Achanta P, Bartberger MD, Canon J, Hollis LS, McCarter JD, Mohr C, Rex K, Saiki AY, San Miguel T, Volak LP, Wang KH, Whittington DA, Zech SG, Lipford JR, Cee VJ (2020) Discovery of a covalent inhibitor of KRASG12C (AMG 510) for the treatment of solid tumors. J Med Chem 63(1):52–65. https://doi.org/10.1021/acs.jmedchem.9b01180 (Epub 2019 Dec 24 PMID: 31820981)

3. LUMAKRAS [package insert] Thousand Oaks, CA: Amgen Inc. 2021

4. Hamilton RA, Garnett WR, Kline BJ (1981) Determination of mean valproic acid serum level by assay of a single pooled sample. Clin Pharmacol Ther 29(3):408–413. https://doi.org/10.1038/clpt.1981.56 (PMID: 6781809)

5. Penner N, Klunk LJ, Prakash C (2009) Human radiolabeled mass balance studies: objectives, utilities and limitations. Biopharm Drug Dispos 30(4):185–203. https://doi.org/10.1002/bdd.661 (PMID: 19544285)

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relative Bioavailability of Sotorasib Following Administration as a Water Dispersion to Healthy Subjects and Compatibility With Enteral Administration;Clinical Pharmacology in Drug Development;2024-09-04

2. Impact of a High‐Fat Meal on the Pharmacokinetics of Sotorasib, a KRAS G12C Inhibitor;Clinical Pharmacology in Drug Development;2024-07-17

3. Effect of Strong CYP3A4 Inhibition, CYP3A4 Induction, and OATP1B1/3 Inhibition on the Pharmacokinetics of a Single Oral Dose of Sotorasib;Clinical Pharmacology in Drug Development;2024-02-29

4. Recent Advances in FDA-Approved Kinase Inhibitors Targeting Lung Cancer;Handbook of Oncobiology: From Basic to Clinical Sciences;2024

5. First-in-Humans PET Imaging ofKRAS^G12CMutation Status in Non–Small Cell Lung and Colorectal Cancer Patients Using [¹⁸F]PFPMD;Journal of Nuclear Medicine;2023-10-12